Skip to content

Clinical trials

Multiple Sclerosis, Relapsing-Remitting trials in the United States with unknown status

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Multiple Sclerosis, Relapsing-Remitting Status: Unknown status Country / region: United States Clear all

14 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20041
20051
20061
20091
20112
20141
20161
20192
20211
20221
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Unknown status14

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Alabama Neurology Associates, PC1
Artielle ImmunoTherapeutics1
Beijing InnoCare Pharma Tech Co., Ltd.1
Berkovich, Regina MD, PhD Inc.1
Institute for Clinical Research1
Kessler Foundation1
Multiple Sclerosis Institute1
Nelson Mandela Metropolitan University1
Shirley Ryan AbilityLab1
Transparency Life Sciences1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Multiple Sclerosis, Relapsing-Remitting14
Multiple Sclerosis9
Multiple Sclerosis, Chronic Progressive3
Ataxia1
Disease Progression1
Fatigue1

Trials

Showing 1 to 14 of 14. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.